StreetInsider.com News Articles

Compass Pathways elects Kathleen Tregoning to board of directors

Thu, 28 May 2026 06:30:18 -0400

Compass Pathways plc (NASDAQ: CMPS) announced that Kathleen Tregoning has been elected to its board of directors at the annual general meeting of shareholders, according to a company statement.

Tregoning is expected to serve on the Compensation and Leadership Development Committee and the Nominating and Corporate Governance Committee. She previously served as Chief Corporate Affairs Officer and Head of Commercial Strategy at Cerevel Therapeutics, where she guided the company through its acquisition by AbbVie in 2024.

Before joining Cerevel, Tregoning held the position of Executive Vice President, External Affairs at Sanofi, where she led global market access, public policy, government affairs, communications,

Compass Pathways elects Kathleen Tregoning to board of directors

Thu, 28 May 2026 06:30:18 -0400

Compass Pathways plc (NASDAQ: CMPS) announced that Kathleen Tregoning has been elected to its board of directors at the annual general meeting of shareholders, according to a company statement.

Before joining Cerevel, Tregoning held the position of Executive Vice President, External Affairs at Sanofi, where she led global market access, public policy, government affairs, communications,

Compass Pathways elects Kathleen Tregoning to board of directors

Thu, 28 May 2026 06:30:18 -0400

Compass Pathways plc (NASDAQ: CMPS) announced that Kathleen Tregoning has been elected to its board of directors at the annual general meeting of shareholders, according to a company statement.

Before joining Cerevel, Tregoning held the position of Executive Vice President, External Affairs at Sanofi, where she led global market access, public policy, government affairs, communications,

Compass Pathways elects Kathleen Tregoning to board of directors

Thu, 28 May 2026 06:30:18 -0400

Compass Pathways plc (NASDAQ: CMPS) announced that Kathleen Tregoning has been elected to its board of directors at the annual general meeting of shareholders, according to a company statement.

Before joining Cerevel, Tregoning held the position of Executive Vice President, External Affairs at Sanofi, where she led global market access, public policy, government affairs, communications,

Compass Pathways elects Kathleen Tregoning to board of directors

Thu, 28 May 2026 06:30:18 -0400

Compass Pathways plc (NASDAQ: CMPS) announced that Kathleen Tregoning has been elected to its board of directors at the annual general meeting of shareholders, according to a company statement.

Before joining Cerevel, Tregoning held the position of Executive Vice President, External Affairs at Sanofi, where she led global market access, public policy, government affairs, communications,

Compass Pathways elects Kathleen Tregoning to board of directors

Thu, 28 May 2026 06:30:18 -0400

Compass Pathways plc (NASDAQ: CMPS) announced that Kathleen Tregoning has been elected to its board of directors at the annual general meeting of shareholders, according to a company statement.

Before joining Cerevel, Tregoning held the position of Executive Vice President, External Affairs at Sanofi, where she led global market access, public policy, government affairs, communications,

Compass Pathways elects Kathleen Tregoning to board of directors

Thu, 28 May 2026 06:30:18 -0400

Compass Pathways plc (NASDAQ: CMPS) announced that Kathleen Tregoning has been elected to its board of directors at the annual general meeting of shareholders, according to a company statement.

Before joining Cerevel, Tregoning held the position of Executive Vice President, External Affairs at Sanofi, where she led global market access, public policy, government affairs, communications,

Compass Pathways elects Kathleen Tregoning to board of directors

Thu, 28 May 2026 06:30:18 -0400

Compass Pathways plc (NASDAQ: CMPS) announced that Kathleen Tregoning has been elected to its board of directors at the annual general meeting of shareholders, according to a company statement.

Before joining Cerevel, Tregoning held the position of Executive Vice President, External Affairs at Sanofi, where she led global market access, public policy, government affairs, communications,

Compass Pathways elects Kathleen Tregoning to board of directors

Thu, 28 May 2026 06:30:18 -0400

Compass Pathways plc (NASDAQ: CMPS) announced that Kathleen Tregoning has been elected to its board of directors at the annual general meeting of shareholders, according to a company statement.

Before joining Cerevel, Tregoning held the position of Executive Vice President, External Affairs at Sanofi, where she led global market access, public policy, government affairs, communications,

Compass Pathways elects Kathleen Tregoning to board of directors

Thu, 28 May 2026 06:30:18 -0400

Compass Pathways plc (NASDAQ: CMPS) announced that Kathleen Tregoning has been elected to its board of directors at the annual general meeting of shareholders, according to a company statement.

Before joining Cerevel, Tregoning held the position of Executive Vice President, External Affairs at Sanofi, where she led global market access, public policy, government affairs, communications,

Compass Pathways elects Kathleen Tregoning to board of directors

Thu, 28 May 2026 06:30:18 -0400

Compass Pathways plc (NASDAQ: CMPS) announced that Kathleen Tregoning has been elected to its board of directors at the annual general meeting of shareholders, according to a company statement.

Before joining Cerevel, Tregoning held the position of Executive Vice President, External Affairs at Sanofi, where she led global market access, public policy, government affairs, communications,

Compass Pathways elects Kathleen Tregoning to board of directors

Thu, 28 May 2026 06:30:18 -0400

Compass Pathways plc (NASDAQ: CMPS) announced that Kathleen Tregoning has been elected to its board of directors at the annual general meeting of shareholders, according to a company statement.

Before joining Cerevel, Tregoning held the position of Executive Vice President, External Affairs at Sanofi, where she led global market access, public policy, government affairs, communications,

Compass Pathways elects Kathleen Tregoning to board of directors

Thu, 28 May 2026 06:30:18 -0400

Compass Pathways plc (NASDAQ: CMPS) announced that Kathleen Tregoning has been elected to its board of directors at the annual general meeting of shareholders, according to a company statement.

Before joining Cerevel, Tregoning held the position of Executive Vice President, External Affairs at Sanofi, where she led global market access, public policy, government affairs, communications,

Compass Pathways elects Kathleen Tregoning to board of directors

Thu, 28 May 2026 06:30:18 -0400

Compass Pathways plc (NASDAQ: CMPS) announced that Kathleen Tregoning has been elected to its board of directors at the annual general meeting of shareholders, according to a company statement.

Before joining Cerevel, Tregoning held the position of Executive Vice President, External Affairs at Sanofi, where she led global market access, public policy, government affairs, communications,

Compass Pathways elects Kathleen Tregoning to board of directors

Thu, 28 May 2026 06:30:18 -0400

Compass Pathways plc (NASDAQ: CMPS) announced that Kathleen Tregoning has been elected to its board of directors at the annual general meeting of shareholders, according to a company statement.

Before joining Cerevel, Tregoning held the position of Executive Vice President, External Affairs at Sanofi, where she led global market access, public policy, government affairs, communications,

Compass Pathways elects Kathleen Tregoning to board of directors

Thu, 28 May 2026 06:30:18 -0400

Compass Pathways plc (NASDAQ: CMPS) announced that Kathleen Tregoning has been elected to its board of directors at the annual general meeting of shareholders, according to a company statement.

Before joining Cerevel, Tregoning held the position of Executive Vice President, External Affairs at Sanofi, where she led global market access, public policy, government affairs, communications,

Compass Pathways Elects Kathleen Tregoning to Board of Directors

Thu, 28 May 2026 06:30:00 -0400

LONDON & NEW YORK--(BUSINESS WIRE)-- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the election of Kathleen Tregoning to its Board of Directors at the annual general meeting of shareholders. Ms. Tregoning is expected to serve on the Compensation and Leadership Development Committee and the Nominating and Corporate Governance Committee. She brings extensive experience guiding biopharmaceutical companies through periods of growth and transformation, with expertise spanning corporate strategy, external affairs, public policy and patient access.

“With two successful Phase 3 trials meeting the primary endpoint,

Compass Pathways Elects Kathleen Tregoning to Board of Directors

Thu, 28 May 2026 06:30:00 -0400

“With two successful Phase 3 trials meeting the primary endpoint,

Compass Pathways Elects Kathleen Tregoning to Board of Directors

Thu, 28 May 2026 06:30:00 -0400

“With two successful Phase 3 trials meeting the primary endpoint,

Compass Pathways Elects Kathleen Tregoning to Board of Directors

Thu, 28 May 2026 06:30:00 -0400

“With two successful Phase 3 trials meeting the primary endpoint,

Compass Pathways Elects Kathleen Tregoning to Board of Directors

Thu, 28 May 2026 06:30:00 -0400

“With two successful Phase 3 trials meeting the primary endpoint,

Compass Pathways Elects Kathleen Tregoning to Board of Directors

Thu, 28 May 2026 06:30:00 -0400

“With two successful Phase 3 trials meeting the primary endpoint,

Compass Pathways Elects Kathleen Tregoning to Board of Directors

Thu, 28 May 2026 06:30:00 -0400

“With two successful Phase 3 trials meeting the primary endpoint,

Compass Pathways Elects Kathleen Tregoning to Board of Directors

Thu, 28 May 2026 06:30:00 -0400

“With two successful Phase 3 trials meeting the primary endpoint,

Compass Pathways Elects Kathleen Tregoning to Board of Directors

Thu, 28 May 2026 06:30:00 -0400

“With two successful Phase 3 trials meeting the primary endpoint,